METTL14 was found to be highly expressed in AML, where it acted as an oncogene via m6A target genes such as MYB proto-oncogene transcription factor (MYB) and MYC.METTL14 silencing leads to inhibition of AML cell growth and survival [65]. The gene discussed is MYB; the disease is acute myeloid leukemia.